New Delhi: Government authorities and pharmaceutical companies have stepped up their game as India is all set to hit the one crore-mark on the number of coronavirus tests amid the Union Home Ministry advice to increase testing and hospitalisation in order to reduce the COVID-19 mortality rate. Notably, the Drug Controller General of India (DCGI) on Friday gave a nod to Zydus Cadila to begin the human trials for its COVID-19 vaccine.Also Read - Kerala Not Yet Free From 2nd Wave, Warns Health Minister as State Logs Over 20,000 Covid Cases For 5th Day | Highlights

India has already breached the 6-lakh mark on the total number of coronavirus cases, with more than 22,000 fresh cases recorded on Thursday evening in a single-day record spike, inching closer each day to surpass Russia on the third position of global COVID-19 chart. Also Read - Haryana Lockdown: Restrictions Extended Till Aug 9, Malls To Remain Open Till 10 PM | Full List of Guidelines Here

Meanwhile, the Ahmedabad-based pharmaceutical firm Zydus Cadila Healthcare Ltd is the second company after Bharat Biotech to get government approval for Phase I and Phase II clinical trials for the experimental vaccine. Zydus Cadila had submitted it successful animal trial data with the regulatory body, where the animal subjects – mice, rabbits, guinea pigs, rats – developed antibodies against the deadly virus. Also Read - THIS Country Declares State of Emergency Amid Spike in Covid-19 Cases | Details

Last week, the Hyderabad-based pharma Bharat Biotech’s COVAXIN, developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), got a central nod to start human trials.

The two companies are expected to begin clinical trials of human subjects this month.

Live Updates

  • 10:27 PM IST

  • 10:26 PM IST

    Coronavirus LIVE Updates: Six personnel of Ranchi police have tested COVID-19 positive. They have been quarantined and are receiving treatment. Their contact tracing within and outside the department is being done: Surendra Kumar Jha, SSP Ranchi

  • 10:24 PM IST

  • 4:58 PM IST

  • 1:51 PM IST

  • 1:16 PM IST

    Coronavirus LIVE: Andhra Pradesh recorded 837 new COVID-19 cases and 8 deaths in the last 24 hours, taking the total number of cases to 16,934 out of which 9,096 cases are active. Number of deaths due to the disease rises to 206.

  • 1:16 PM IST

    Coronavirus LIVE: Uttarakhand Government constitutes a technical committee to provide inputs to the government on COVID19 containment in the state.

  • 11:44 AM IST

    Coronavirus LIVE: Hyderabad-based Bharat Biotech, that partnered with ICMR for COVID-19 vaccine, will release Phase I human trial results by August 15.

  • 10:22 AM IST

    Coronavirus LIVE: India’s recovery rate stands at 60.7 per cent.

  • 10:02 AM IST

    Coronavirus LIVE: Four fresh COVID-19 positive cases have been reported in Nagaland today, taking the total number of cases to 539 including 342 active cases, 197 recoveries and no deaths so far.